<p>隨着全球市場面臨不斷上升的通貨膨脹和地緣政治不確定性，亞洲股票為尋求價值的投資者提供了引人注目的機會。在這種環境下，識別那些交易價格顯著低於其內在價值的股票尤其具有吸引力，當市場條件穩定時，這些股票可能會帶來增長潛力。</p>
<h3>基於現金流的亞洲十大被低估股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>當前價格</strong></td>
<td><strong>公允價值（估計）</strong></td>
<td><strong>折扣（估計）</strong></td>
</tr>
<tr>
<td>Strike Group (TSE:6196)</td>
<td>¥1212.00</td>
<td>¥2378.82</td>
<td>49.1%</td>
</tr>
<tr>
<td>Plus Alpha ConsultingLtd (TSE:4071)</td>
<td>¥2394.00</td>
<td>¥4703.99</td>
<td>49.1%</td>
</tr>
<tr>
<td>NTT DC REIT (SGX:NTDU)</td>
<td>US$0.98</td>
<td>US$1.94</td>
<td>49.5%</td>
</tr>
<tr>
<td>Moshi Moshi Retail Corporation (SET:MOSHI)</td>
<td>THB36.25</td>
<td>THB69.86</td>
<td>48.1%</td>
</tr>
<tr>
<td>LianChuang Electronic TechnologyLtd (SZSE:002036)</td>
<td>CN¥8.83</td>
<td>CN¥17.24</td>
<td>48.8%</td>
</tr>
<tr>
<td>Intco Medical Technology (SZSE:300677)</td>
<td>CN¥50.44</td>
<td>CN¥100.72</td>
<td>49.9%</td>
</tr>
<tr>
<td>Cybozu (TSE:4776)</td>
<td>¥2449.00</td>
<td>¥4865.51</td>
<td>49.7%</td>
</tr>
<tr>
<td>北京露珠生物科技 (SEHK:2480)</td>
<td>HK$19.70</td>
<td>HK$39.26</td>
<td>49.8%</td>
</tr>
<tr>
<td>BEAUTY GARAGE (TSE:3180)</td>
<td>¥1455.00</td>
<td>¥2824.07</td>
<td>48.5%</td>
</tr>
<tr>
<td>APR (KOSE:A278470)</td>
<td>₩397500.00</td>
<td>₩782216.21</td>
<td>49.2%</td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們基於現金流的 195 只被低估亞洲股票的完整列表。</p>
<p>下面我們展示了一些通過我們的篩選器篩選出的股票。</p>
<h2>Plus Alpha ConsultingLtd (TSE:4071)</h2>
<p><strong>概述：</strong> Plus Alpha Consulting Co., Ltd. 在日本提供市場營銷和人力資源解決方案，市值為¥1014.8 億。</p>
<p><strong>運營：</strong> Plus Alpha Consulting Co., Ltd. 通過其在日本的市場營銷和人力資源解決方案產生收入。</p>
<p><strong>公允價值折扣估計：</strong> 49.1%</p>
<p>Plus Alpha Consulting Ltd. 的交易價格為¥2,394，顯著低於其估計的未來現金流價值¥4,703.99，表明其可能被低估。儘管預計年收入增長率為 12.6%——高於日本市場的平均水平，但公司的盈利預計將以每年 17.5% 的速度增長，超過市場的 8.8%。最近董事會討論提高股息支付比例，可能進一步增強股東回報。</p>
<ul>
<li>我們編制的增長報告表明，Plus Alpha ConsultingLtd 的未來前景可能向好。</li>
<li>點擊這裏深入瞭解 Plus Alpha ConsultingLtd 的資產負債表。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/a6c28592-bcb7-4305-8f5b-f6b1e621ab4b/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/a6c28592-bcb7-4305-8f5b-f6b1e621ab4b/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>TSE:4071 截至 2026 年 5 月的折現現金流</p>
<h2>Medley (TSE:4480)</h2>
<p><strong>概述：</strong> Medley, Inc. 在日本和美國運營招聘和醫療業務平台，市值為¥67.96 億。</p>
<p><strong>運營：</strong> 公司的收入部分包括生成¥123.4 億的招聘平台和貢獻¥85.6 億的醫療業務平台。</p>
<p><strong>公允價值折扣估計：</strong> 33.7%</p>
<p>Medley, Inc. 的交易價格為¥2,260，低於其估計的未來現金流價值¥3,408.64，反映出基於現金流的潛在低估。預計未來三年盈利將以 29.7% 的速度顯著增長，超過日本市場的平均增長率 8.8%。然而，利潤率已從 7.2% 降至 2.5%。最近的戰略舉措包括股票回購和計劃收購 Recruit Medical Career Co., Ltd.的業務作為子公司。</p>
<ul>
<li>我們的增長報告表明，Medley 可能正處於改善的前景中。</li>
<li>點擊這裏瞭解 Medley 的詳細財務健康報告。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/54ac06f7-e3c9-443c-baec-dd705f917a22/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/54ac06f7-e3c9-443c-baec-dd705f917a22/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>TSE:4480 截至 2026 年 5 月的折現現金流</p>
<h2>Socionext (TSE:6526)</h2>
<p><strong>概述：</strong> Socionext Inc. 是一家全球公司，設計、開發、製造和銷售系統級芯片（SoC）及相關解決方案/服務，市值為¥403.49 億。</p>
<p><strong>運營：</strong> 公司的收入部分主要由開發的 SoC 組成，金額為¥200.83 百萬。</p>
<p><strong>公允價值折扣估計：</strong> 38.4%</p>
<p>Socionext Inc. 的交易價格為¥2,302，顯著低於其估計的未來現金流價值¥3,734.2，表明基於現金流的低估。預計未來三年盈利將以 29% 的速度顯著增長，超過日本市場的平均增長。然而，利潤率已從 10.4% 降至 4.3%，儘管最近確認了股息和 2027 財年的指導更新，但股息仍未得到盈利或自由現金流的充分覆蓋。</p>
<ul>
<li>我們精心準備的 Socionext 增長報告暗示其未來財務前景可能比最近的結果更強勁。</li>
<li>點擊探索我們在 Socionext 資產負債表健康報告中的詳細發現。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7e3f0549-c053-4237-ab72-0dc41dca9664/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7e3f0549-c053-4237-ab72-0dc41dca9664/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>TSE:6526 截至 2026 年 5 月的折現現金流</p>
<h2>關鍵要點</h2>
<ul>
<li>點擊這裏揭示我們基於現金流的 195 只被低估亞洲股票中的隱藏寶石。</li>
<li>這些公司是否是您投資策略的一部分？使用 Simply Wall St 將您的持股整合到一個投資組合中，並通過我們的綜合分析工具獲得洞察。</li>
<li>Simply Wall St 是您解鎖全球市場趨勢的關鍵，是一款面向前瞻性投資者的免費用户友好應用。</li>
</ul>
<h2>對其他可能性感興趣嗎？</h2>
<ul>
<li>探索尚未獲得顯著分析師關注的高表現小型公司。</li>
<li>通過提供可靠收入流的穩健分紅股票來分散您的投資組合，以應對潛在的市場動盪。</li>
<li>通過分析師和管理層的樂觀前景，推動您的投資組合中顯示強勁增長潛力的公司。</li>
</ul>
<p><em>這篇來自 Simply Wall St 的文章是一般性的。<strong>我們提供基於歷史數據和分析師預測的評論，僅使用無偏見的方法，我們的文章並不旨在提供財務建議。它不構成買賣任何股票的推薦，也未考慮您的目標或財務狀況。</strong> 我們旨在為您帶來以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
<h3><strong>新功能：</strong> 在一個地方管理您的所有股票投資組合</h3>
<p>我們為股票投資者創建了 <strong>終極投資組合助手</strong>，<strong>而且是免費的。</strong></p>
<p>• 連接無限數量的投資組合，並以一種貨幣查看您的總額</p>
<p>• 通過電子郵件或手機接收新的警告信號或風險提示</p>
<p>• 跟蹤您股票的公允價值</p>
<p>免費試用演示投資組合</p>

4071

4480

<p>亞洲股票目前呈現出投資機會，像 Plus Alpha Consulting、Medley 和 Socionext 等股票的內在價值被估計低估了 33.7% 至 49.1%。這些公司顯示出增長潛力，儘管面臨一些挑戰，預計收益將超過市場平均水平。投資者被鼓勵在市場條件穩定時探索這些被低估的股票</p>

<p>As global markets grapple with rising inflation and geopolitical uncertainties, Asian equities present intriguing opportunities for investors seeking value. In this environment, identifying stocks that are trading significantly below their intrinsic value can be particularly appealing, offering potential for growth when market conditions stabilize.</p>
<div class="lb-trans"><p>隨着全球市場面臨不斷上升的通貨膨脹和地緣政治不確定性，亞洲股票為尋求價值的投資者提供了引人注目的機會。在這種環境下，識別那些交易價格顯著低於其內在價值的股票尤其具有吸引力，當市場條件穩定時，這些股票可能會帶來增長潛力。</p>
</div><h3>Top 10 Undervalued Stocks Based On Cash Flows In Asia</h3>
<div class="lb-trans"><h3>基於現金流的亞洲十大被低估股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Current Price</strong></td>
<td><strong>Fair Value (Est)</strong></td>
<td><strong>Discount (Est)</strong></td>
</tr>
<tr>
<td>Strike Group (TSE:6196)</td>
<td>¥1212.00</td>
<td>¥2378.82</td>
<td>49.1%</td>
</tr>
<tr>
<td>Plus Alpha ConsultingLtd (TSE:4071)</td>
<td>¥2394.00</td>
<td>¥4703.99</td>
<td>49.1%</td>
</tr>
<tr>
<td>NTT DC REIT (SGX:NTDU)</td>
<td>US$0.98</td>
<td>US$1.94</td>
<td>49.5%</td>
</tr>
<tr>
<td>Moshi Moshi Retail Corporation (SET:MOSHI)</td>
<td>THB36.25</td>
<td>THB69.86</td>
<td>48.1%</td>
</tr>
<tr>
<td>LianChuang Electronic TechnologyLtd (SZSE:002036)</td>
<td>CN¥8.83</td>
<td>CN¥17.24</td>
<td>48.8%</td>
</tr>
<tr>
<td>Intco Medical Technology (SZSE:300677)</td>
<td>CN¥50.44</td>
<td>CN¥100.72</td>
<td>49.9%</td>
</tr>
<tr>
<td>Cybozu (TSE:4776)</td>
<td>¥2449.00</td>
<td>¥4865.51</td>
<td>49.7%</td>
</tr>
<tr>
<td>Beijing Luzhu Biotechnology (SEHK:2480)</td>
<td>HK$19.70</td>
<td>HK$39.26</td>
<td>49.8%</td>
</tr>
<tr>
<td>BEAUTY GARAGE (TSE:3180)</td>
<td>¥1455.00</td>
<td>¥2824.07</td>
<td>48.5%</td>
</tr>
<tr>
<td>APR (KOSE:A278470)</td>
<td>₩397500.00</td>
<td>₩782216.21</td>
<td>49.2%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>當前價格</strong></td>
<td><strong>公允價值（估計）</strong></td>
<td><strong>折扣（估計）</strong></td>
</tr>
<tr>
<td>Strike Group (TSE:6196)</td>
<td>¥1212.00</td>
<td>¥2378.82</td>
<td>49.1%</td>
</tr>
<tr>
<td>Plus Alpha ConsultingLtd (TSE:4071)</td>
<td>¥2394.00</td>
<td>¥4703.99</td>
<td>49.1%</td>
</tr>
<tr>
<td>NTT DC REIT (SGX:NTDU)</td>
<td>US$0.98</td>
<td>US$1.94</td>
<td>49.5%</td>
</tr>
<tr>
<td>Moshi Moshi Retail Corporation (SET:MOSHI)</td>
<td>THB36.25</td>
<td>THB69.86</td>
<td>48.1%</td>
</tr>
<tr>
<td>LianChuang Electronic TechnologyLtd (SZSE:002036)</td>
<td>CN¥8.83</td>
<td>CN¥17.24</td>
<td>48.8%</td>
</tr>
<tr>
<td>Intco Medical Technology (SZSE:300677)</td>
<td>CN¥50.44</td>
<td>CN¥100.72</td>
<td>49.9%</td>
</tr>
<tr>
<td>Cybozu (TSE:4776)</td>
<td>¥2449.00</td>
<td>¥4865.51</td>
<td>49.7%</td>
</tr>
<tr>
<td>北京露珠生物科技 (SEHK:2480)</td>
<td>HK$19.70</td>
<td>HK$39.26</td>
<td>49.8%</td>
</tr>
<tr>
<td>BEAUTY GARAGE (TSE:3180)</td>
<td>¥1455.00</td>
<td>¥2824.07</td>
<td>48.5%</td>
</tr>
<tr>
<td>APR (KOSE:A278470)</td>
<td>₩397500.00</td>
<td>₩782216.21</td>
<td>49.2%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 195 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們基於現金流的 195 只被低估亞洲股票的完整列表。</p>
</div><p>Underneath we present a selection of stocks filtered out by our screen.</p>
<div class="lb-trans"><p>下面我們展示了一些通過我們的篩選器篩選出的股票。</p>
</div><h2>Plus Alpha ConsultingLtd (TSE:4071)</h2>
<div class="lb-trans"><h2>Plus Alpha ConsultingLtd (TSE:4071)</h2>
</div><p><strong>Overview:</strong> Plus Alpha Consulting Co., Ltd. offers marketing and HR solutions in Japan, with a market cap of ¥101.48 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Plus Alpha Consulting Co., Ltd. 在日本提供市場營銷和人力資源解決方案，市值為¥1014.8 億。</p>
</div><p><strong>Operations:</strong> Plus Alpha Consulting Co., Ltd. generates revenue through its marketing and human resources solutions in Japan.</p>
<div class="lb-trans"><p><strong>運營：</strong> Plus Alpha Consulting Co., Ltd. 通過其在日本的市場營銷和人力資源解決方案產生收入。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 49.1%</p>
<div class="lb-trans"><p><strong>公允價值折扣估計：</strong> 49.1%</p>
</div><p>Plus Alpha Consulting Ltd. is trading at ¥2,394, significantly below its estimated future cash flow value of ¥4,703.99, indicating it may be undervalued based on cash flows. Despite a moderate revenue growth forecast of 12.6% annually—higher than the Japanese market's average—the company's earnings are expected to grow at 17.5% per year, outpacing the market's 8.8%. Recent board discussions about increasing dividend payout ratios could enhance shareholder returns further.</p>
<div class="lb-trans"><p>Plus Alpha Consulting Ltd. 的交易價格為¥2,394，顯著低於其估計的未來現金流價值¥4,703.99，表明其可能被低估。儘管預計年收入增長率為 12.6%——高於日本市場的平均水平，但公司的盈利預計將以每年 17.5% 的速度增長，超過市場的 8.8%。最近董事會討論提高股息支付比例，可能進一步增強股東回報。</p>
</div><ul>
<li>The growth report we've compiled suggests that Plus Alpha ConsultingLtd's future prospects could be on the up.</li>
<li>Get an in-depth perspective on Plus Alpha ConsultingLtd's balance sheet by reading our health report here.</li>
</ul>
<div class="lb-trans"><ul>
<li>我們編制的增長報告表明，Plus Alpha ConsultingLtd 的未來前景可能向好。</li>
<li>點擊這裏深入瞭解 Plus Alpha ConsultingLtd 的資產負債表。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/a6c28592-bcb7-4305-8f5b-f6b1e621ab4b/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/a6c28592-bcb7-4305-8f5b-f6b1e621ab4b/chart/dcf?theme=light"/></p>
<p>TSE:4071 Discounted Cash Flow as at May 2026</p>
<div class="lb-trans"><p>TSE:4071 截至 2026 年 5 月的折現現金流</p>
</div><h2>Medley (TSE:4480)</h2>
<div class="lb-trans"><h2>Medley (TSE:4480)</h2>
</div><p><strong>Overview:</strong> Medley, Inc. operates platforms for recruitment and medical businesses in Japan and the United States, with a market cap of ¥67.96 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Medley, Inc. 在日本和美國運營招聘和醫療業務平台，市值為¥67.96 億。</p>
</div><p><strong>Operations:</strong> The company's revenue segments include recruitment platforms generating ¥12.34 billion and medical business platforms contributing ¥8.56 billion.</p>
<div class="lb-trans"><p><strong>運營：</strong> 公司的收入部分包括生成¥123.4 億的招聘平台和貢獻¥85.6 億的醫療業務平台。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 33.7%</p>
<div class="lb-trans"><p><strong>公允價值折扣估計：</strong> 33.7%</p>
</div><p>Medley, Inc. is trading at ¥2,260, below its estimated future cash flow value of ¥3,408.64, reflecting potential undervaluation based on cash flows. Earnings are projected to grow significantly at 29.7% annually over the next three years, surpassing the Japanese market's average growth rate of 8.8%. However, profit margins have decreased from 7.2% to 2.5%. Recent strategic moves include a share buyback and plans to acquire Recruit Medical Career Co., Ltd.'s business operations as a subsidiary.</p>
<div class="lb-trans"><p>Medley, Inc. 的交易價格為¥2,260，低於其估計的未來現金流價值¥3,408.64，反映出基於現金流的潛在低估。預計未來三年盈利將以 29.7% 的速度顯著增長，超過日本市場的平均增長率 8.8%。然而，利潤率已從 7.2% 降至 2.5%。最近的戰略舉措包括股票回購和計劃收購 Recruit Medical Career Co., Ltd.的業務作為子公司。</p>
</div><ul>
<li>Our growth report here indicates Medley may be poised for an improving outlook.</li>
<li>Click here to discover the nuances of Medley with our detailed financial health report.</li>
</ul>
<div class="lb-trans"><ul>
<li>我們的增長報告表明，Medley 可能正處於改善的前景中。</li>
<li>點擊這裏瞭解 Medley 的詳細財務健康報告。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/54ac06f7-e3c9-443c-baec-dd705f917a22/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/54ac06f7-e3c9-443c-baec-dd705f917a22/chart/dcf?theme=light"/></p>
<p>TSE:4480 Discounted Cash Flow as at May 2026</p>
<div class="lb-trans"><p>TSE:4480 截至 2026 年 5 月的折現現金流</p>
</div><h2>Socionext (TSE:6526)</h2>
<div class="lb-trans"><h2>Socionext (TSE:6526)</h2>
</div><p><strong>Overview:</strong> Socionext Inc. is a global company that designs, develops, manufactures, and sells system-on-chip (SoC) and related solutions/services, with a market cap of ¥403.49 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Socionext Inc. 是一家全球公司，設計、開發、製造和銷售系統級芯片（SoC）及相關解決方案/服務，市值為¥403.49 億。</p>
</div><p><strong>Operations:</strong> The company's revenue segment primarily consists of SoC developed with The Solution SoC, amounting to ¥200.83 million.</p>
<div class="lb-trans"><p><strong>運營：</strong> 公司的收入部分主要由開發的 SoC 組成，金額為¥200.83 百萬。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 38.4%</p>
<div class="lb-trans"><p><strong>公允價值折扣估計：</strong> 38.4%</p>
</div><p>Socionext Inc. is trading at ¥2,302, significantly below its estimated future cash flow value of ¥3,734.2, suggesting undervaluation based on cash flows. Earnings are expected to grow substantially at 29% annually over the next three years, outpacing the Japanese market's average growth. However, profit margins have declined from 10.4% to 4.3%, and dividends remain inadequately covered by earnings or free cash flows despite recent dividend affirmations and guidance updates for fiscal year 2027.</p>
<div class="lb-trans"><p>Socionext Inc. 的交易價格為¥2,302，顯著低於其估計的未來現金流價值¥3,734.2，表明基於現金流的低估。預計未來三年盈利將以 29% 的速度顯著增長，超過日本市場的平均增長。然而，利潤率已從 10.4% 降至 4.3%，儘管最近確認了股息和 2027 財年的指導更新，但股息仍未得到盈利或自由現金流的充分覆蓋。</p>
</div><ul>
<li>Our expertly prepared growth report on Socionext implies its future financial outlook may be stronger than recent results.</li>
<li>Click to explore a detailed breakdown of our findings in Socionext's balance sheet health report.</li>
</ul>
<div class="lb-trans"><ul>
<li>我們精心準備的 Socionext 增長報告暗示其未來財務前景可能比最近的結果更強勁。</li>
<li>點擊探索我們在 Socionext 資產負債表健康報告中的詳細發現。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7e3f0549-c053-4237-ab72-0dc41dca9664/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/7e3f0549-c053-4237-ab72-0dc41dca9664/chart/dcf?theme=light"/></p>
<p>TSE:6526 Discounted Cash Flow as at May 2026</p>
<div class="lb-trans"><p>TSE:6526 截至 2026 年 5 月的折現現金流</p>
</div><h2>Key Takeaways</h2>
<div class="lb-trans"><h2>關鍵要點</h2>
</div><ul>
<li>Reveal the 195 hidden gems among our Undervalued Asian Stocks Based On Cash Flows screener with a single click here.</li>
<li>Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.</li>
<li>Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏揭示我們基於現金流的 195 只被低估亞洲股票中的隱藏寶石。</li>
<li>這些公司是否是您投資策略的一部分？使用 Simply Wall St 將您的持股整合到一個投資組合中，並通過我們的綜合分析工具獲得洞察。</li>
<li>Simply Wall St 是您解鎖全球市場趨勢的關鍵，是一款面向前瞻性投資者的免費用户友好應用。</li>
</ul>
</div><h2>Interested In Other Possibilities?</h2>
<div class="lb-trans"><h2>對其他可能性感興趣嗎？</h2>
</div><ul>
<li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li>
<li>Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.</li>
<li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li>
</ul>
<div class="lb-trans"><ul>
<li>探索尚未獲得顯著分析師關注的高表現小型公司。</li>
<li>通過提供可靠收入流的穩健分紅股票來分散您的投資組合，以應對潛在的市場動盪。</li>
<li>通過分析師和管理層的樂觀前景，推動您的投資組合中顯示強勁增長潛力的公司。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation.</strong> We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>這篇來自 Simply Wall St 的文章是一般性的。<strong>我們提供基於歷史數據和分析師預測的評論，僅使用無偏見的方法，我們的文章並不旨在提供財務建議。它不構成買賣任何股票的推薦，也未考慮您的目標或財務狀況。</strong> 我們旨在為您帶來以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
</div><h3><strong>New:</strong> Manage All Your Stock Portfolios in One Place</h3>
<div class="lb-trans"><h3><strong>新功能：</strong> 在一個地方管理您的所有股票投資組合</h3>
</div><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p>
<div class="lb-trans"><p>我們為股票投資者創建了 <strong>終極投資組合助手</strong>，<strong>而且是免費的。</strong></p>
</div><p>• Connect an unlimited number of Portfolios and see your total in one currency</p>
<div class="lb-trans"><p>• 連接無限數量的投資組合，並以一種貨幣查看您的總額</p>
</div><p>• Be alerted to new Warning Signs or Risks via email or mobile</p>
<div class="lb-trans"><p>• 通過電子郵件或手機接收新的警告信號或風險提示</p>
</div><p>• Track the Fair Value of your stocks</p>
<div class="lb-trans"><p>• 跟蹤您股票的公允價值</p>
</div><p>Try a Demo Portfolio for Free</p>
<div class="lb-trans"><p>免費試用演示投資組合</p>
</div>

三隻亞洲股票被估計低於其內在價值 33.7% 至 49.1%